Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
The latest announcement is out from DBV Technologies SA – American ( (DBVT) ).
DBV Technologies Inc., a subsidiary of DBV Technologies S.A., has amended employment agreements for its Chief Medical Officer, Pharis Mohideen, and Chief Financial Officer, Virginie Boucinha, to include enhanced severance benefits in the event of a Change in Control. These amendments, approved by the Board of Directors, provide specific financial compensations and benefits to the executives if their employment is terminated under certain conditions following a Change in Control, reflecting the company’s commitment to retaining key leadership during potential organizational changes.
More about DBV Technologies SA – American
YTD Price Performance: -66.32%
Average Trading Volume: 249,591
Technical Sentiment Consensus Rating: Strong Buy
Current Market Cap: $64.5M
For detailed information about DBVT stock, go to TipRanks’ Stock Analysis page.
